| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥97.0B | ¥96.0B | +1.1% |
| Operating Income | ¥4.5B | ¥4.8B | -6.6% |
| Ordinary Income | ¥5.0B | ¥5.2B | -4.7% |
| Net Income | ¥3.6B | ¥3.5B | +3.7% |
| ROE | 2.9% | 2.9% | - |
FY2026 Q3 cumulative results show revenue of 97.0 billion yen (YoY +1.1%), operating income of 4.5 billion yen (YoY -6.6%), ordinary income of 5.0 billion yen (YoY -4.7%), and net income of 3.6 billion yen (YoY +3.7%). Revenue remained essentially flat with modest growth, while operating profitability declined due to elevated SG&A expenses of 41.1 billion yen despite maintaining a gross profit margin of 47.1%. The gap between operating and net income narrowed as net income grew 3.7% supported by non-operating income including dividend income of 0.6 billion yen. EPS increased 3.4% to 88.64 yen. This represents a revenue stable, profit mixed pattern with top-line holding steady but mid-line operating profit declining while bottom-line net income improved through financial income contributions.
Revenue increased 1.1% YoY to 97.0 billion yen, reflecting stable but modest demand across business segments. The Solution Business Division generated sales of 61.5 billion yen with operating income of 5.9 billion yen, representing the core profit driver. The Consumer Business Division recorded sales of 35.5 billion yen but posted an operating loss of 1.3 billion yen, continuing its unprofitable trajectory from the prior year's loss of 0.8 billion yen. The Consumer segment's deteriorating profitability offset gains in the Solution segment, resulting in consolidated operating income declining 6.6% to 4.5 billion yen. Gross profit margin held firm at 47.1%, indicating product-level pricing and cost structure remained intact, but SG&A expenses of 41.1 billion yen represented 42.4% of revenue, compressing operating margin to just 4.7%. The decline from prior year operating income of 4.8 billion yen was primarily attributable to fixed selling expenses and administrative costs growing faster than revenue. Ordinary income of 5.0 billion yen benefited from non-operating income of approximately 0.5 billion yen, including equity method investment gains and dividend income of 0.6 billion yen, partially cushioning the operating profit decline. The difference between ordinary income (5.0 billion yen) and net income (3.6 billion yen) reflects an effective tax burden with profit before tax at 5.0 billion yen and tax expense reducing net income by approximately 28%. Net income growth of 3.7% despite operating income decline indicates reliance on non-operating financial income to sustain bottom-line performance. This constitutes a revenue up, profit mixed pattern where top-line stability masks underlying operating margin pressure and dependence on financial income.
The Solution Business Division represents the core business, generating sales of 61.5 billion yen and operating income of 5.9 billion yen with a segment margin of approximately 9.5%. This segment grew sales modestly and maintained solid profitability, contributing the entirety of consolidated operating profit. The Consumer Business Division recorded sales of 35.5 billion yen but posted an operating loss of 1.3 billion yen, worsening from the prior year loss of 0.8 billion yen and representing a negative margin of -3.5%. The Consumer segment's losses increased by 0.5 billion yen YoY, indicating structural challenges in cost recovery or competitive pricing pressure. The material margin difference between segments is substantial, with Solution generating healthy positive margins while Consumer remains loss-making. The consolidated operating income of 4.5 billion yen reflects the Solution segment's 5.9 billion yen profit net of Consumer's 1.3 billion yen loss, highlighting the concentration of profitability in Solution and the drag from Consumer operations.
[Profitability] ROE of 2.9% remains subdued, substantially below the company's capital cost and indicating weak equity efficiency. Operating margin of 4.7% decreased from prior levels, with gross margin of 47.1% compressed by SG&A ratio of 42.4%. Net profit margin stands at 3.7%, constrained by operating efficiency challenges despite non-operating income support. DuPont 3-factor decomposition shows ROE of 2.9% driven by net margin 3.7%, asset turnover 0.53x, and financial leverage 1.43x, with the primary weakness being low profitability and utilization. [Cash Quality] Cash and deposits decreased significantly to 8.4 billion yen from 19.4 billion yen YoY, representing a 56.8% decline and substantially reducing liquidity buffers. Short-term debt coverage stands at 0.35x based on cash versus current liabilities of 23.8 billion yen, though current assets of 74.8 billion yen provide broader coverage. [Investment Efficiency] Asset turnover of 0.53x indicates moderate asset utilization, while extended receivables and inventory turnover days signal working capital efficiency deterioration. [Financial Health] Equity ratio of 69.8% remains robust, indicating conservative capital structure. Current ratio of 314.9% appears strong, though cash decline warrants monitoring. Debt-to-equity ratio of 0.43x and interest-bearing debt of 12.2 billion yen represent low leverage, with interest coverage approximately 30x based on operating income versus interest expense of 0.15 billion yen.
Cash and deposits decreased 11.0 billion yen YoY to 8.4 billion yen, a 56.8% decline representing the most significant balance sheet movement and raising liquidity attention. Operating profit growth was absent, yet net income of 3.6 billion yen suggests some cash generation capability, though the substantial cash decline indicates material outflows exceeded operating cash generation. Working capital changes show accounts receivable at 27.6 billion yen and inventories at 11.2 billion yen, both at levels suggesting extended collection and holding periods that tie up cash. The cash reduction combined with working capital levels implies cash was deployed to maintain operations, fund investments, or distribute to shareholders, while operating cash conversion remained insufficient to replenish balances. Investment securities increased 5.7 billion yen to 44.3 billion yen, indicating asset reallocation from cash to securities, potentially contributing to the cash decline. Current liabilities remained manageable at 23.8 billion yen, and the company maintains adequate current assets of 74.8 billion yen for near-term obligations, though the diminished cash position reduces financial flexibility and may constrain dividend sustainability or growth investment if cash generation does not improve.
Ordinary income of 5.0 billion yen versus operating income of 4.5 billion yen shows net non-operating contribution of approximately 0.5 billion yen, representing 0.5% of revenue and comprising primarily dividend income of 0.6 billion yen and interest income. This modest non-operating income supports ordinary income but does not materially distort core operating performance. The contribution of financial income remains within reasonable bounds, though ongoing reliance on investment income to supplement operating profit indicates that business profitability alone is constrained. Profit before tax of 5.0 billion yen translates to net income of 3.6 billion yen, reflecting an effective tax burden ratio of 72.6%, which appears elevated potentially due to non-deductible expenses or regional tax effects. Comprehensive income reached 7.6 billion yen, significantly exceeding net income due to other comprehensive income of approximately 4.0 billion yen, primarily from valuation gains on investment securities as the securities portfolio increased 5.7 billion yen. This indicates that comprehensive income benefits materially from unrealized gains, enhancing reported equity but not representing operational cash earnings. Operating cash flow data is unavailable for Q3, preventing direct assessment of cash earnings quality, though the severe cash decline of 11.0 billion yen against net income of 3.6 billion yen suggests working capital absorption or outflows exceeded accrual earnings, raising concerns about earnings conversion to cash.
Full-year guidance targets revenue of 128.0 billion yen, operating income of 9.0 billion yen, ordinary income of 9.5 billion yen, and net income of 7.2 billion yen. Q3 cumulative progress shows revenue at 97.0 billion yen representing 75.8% of full-year target, operating income at 4.5 billion yen representing 50.0%, ordinary income at 5.0 billion yen representing 52.6%, and net income at 3.6 billion yen representing 50.0%. Revenue progress of 75.8% at Q3 is above the standard 75% pace, indicating slightly ahead tracking. Operating income and net income progress at 50.0% is in line with the standard Q2 pace of 50% but below the expected Q3 pace of 75%, suggesting Q4 requires substantial profit acceleration to achieve full-year targets. The company requires 4.5 billion yen of operating income in Q4 alone to reach the 9.0 billion yen target, representing 50% of full-year operating income in the final quarter, which implies a significant seasonal weighting or operational improvement assumption. The forecast implies operating margin recovery to approximately 7.0% for the full year from the current 4.7% Q3 rate, necessitating either revenue acceleration, cost reduction, or mix improvement in Q4. Full-year dividend forecast of 65.00 yen per share implies payout ratio of approximately 37% against forecasted EPS of 176.26 yen, which appears sustainable if earnings targets are met. Progress assessment indicates revenue on track but profit delivery depends critically on Q4 execution.
Annual dividend forecast stands at 65.00 yen per share for the full year, compared to historical levels, representing the company's return commitment. Based on forecasted full-year EPS of 176.26 yen, the payout ratio calculates to 36.9%, which is within sustainable range for mature companies. Measured against Q3 cumulative EPS of 88.64 yen, the interim payout consideration would represent approximately 73% if applied to trailing performance, though full-year guidance suggests improved Q4 earnings will normalize the ratio. Cash dividends paid during the period are not disclosed in the provided data, preventing analysis of actual distributions versus accruals. Share buyback activity is not reported in the available data. The forecasted dividend of 65.00 yen against net income forecast of 7.2 billion yen on approximately 40.95 million shares calculates to total dividend outlay of approximately 2.7 billion yen, representing a 37% payout ratio. This level preserves capital for reinvestment and appears sustainable if full-year earnings are achieved, though the significant cash decline of 11.0 billion yen raises questions about free cash flow adequacy to support dividends without drawing down reserves.
Consumer Business Division structural losses present the primary risk, with the segment posting operating loss of 1.3 billion yen in Q3 cumulative results, worsening from 0.8 billion yen in the prior year. This 63% deterioration in segment losses indicates persistent challenges in achieving profitability, and continued losses could require restructuring or exit, impacting consolidated earnings stability. The segment represents approximately 37% of revenue but contributes negative margins, creating earnings drag that offsets Solution Business strength. Cash position deterioration of 56.8% YoY to 8.4 billion yen represents the second critical risk, as reduced liquidity constrains financial flexibility for growth investment, working capital management, and shareholder returns. If operating cash generation does not recover, the company may face pressure to reduce dividends, curtail investment, or draw on credit facilities. Working capital efficiency decline, evidenced by extended receivables and inventory holding periods, presents the third risk as it ties up cash and may signal demand weakness, collection challenges, or inventory obsolescence. Deteriorating working capital turnover can lead to further cash consumption, margin pressure from markdowns, and potential asset impairments if inventory values decline.
[Industry Position] (Reference - Proprietary Analysis) The company operates in the pharmaceutical industry, where median metrics reflect a sector characterized by high R&D intensity, extended product development cycles, and significant regulatory requirements. Profitability comparison shows the company's ROE of 2.9% exceeds the industry median of -35.8% (Q3 2025, n=13), indicating the company maintains positive equity returns while many industry peers report losses during development phases. The company's operating margin of 4.7% substantially outperforms the industry median of -218.2%, demonstrating operational profitability versus sector-wide negative margins. Net profit margin of 3.7% similarly exceeds the industry median of -216.8%, confirming the company's relative earnings strength. Financial health metrics show equity ratio of 69.8% aligns closely with industry median of 67.8% (IQR: 62.1%-79.1%), indicating comparable conservative capital structures typical of the sector. Current ratio of 314.9% is below the industry median of 662%, suggesting the company maintains tighter working capital relative to highly liquid peers, though still indicating strong short-term solvency. Efficiency comparison reveals asset turnover of 0.53x substantially exceeds industry median of 0.17x, demonstrating superior asset utilization and commercial-stage revenue generation versus development-stage competitors. Revenue growth of 1.1% outperforms the industry median decline of -12.5%, indicating market share gains or product lifecycle advantages. The company's positive profitability and revenue stability position it favorably within an industry characterized by loss-making R&D-stage companies, though its profitability levels remain modest in absolute terms and lag typical commercial pharmaceutical companies outside this peer set. Industry: Pharmaceutical sector (13 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis.
The company demonstrates stability and profitability within a challenging pharmaceutical industry context, maintaining positive operating margins and equity returns while many peers report losses, indicating successful commercialization relative to development-stage competitors. The Solution Business Division functions as the core profit engine with healthy 9.5% segment margins, while Consumer Business losses present a structural challenge requiring strategic resolution through turnaround, restructuring, or exit to unlock consolidated margin improvement. Cash position deterioration of 56.8% YoY represents the most significant near-term concern, with liquidity declining from 19.4 billion yen to 8.4 billion yen, raising questions about free cash flow generation adequacy and sustainability of dividends, growth investment, and working capital funding absent material improvement in cash conversion. The company's conservative capital structure with 69.8% equity ratio and modest leverage provides financial stability and capacity to address operational challenges, though low ROE of 2.9% indicates suboptimal capital efficiency and limited equity value creation requiring margin expansion or asset productivity enhancement.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.